{
  "cik": 1863127,
  "cik_padded": "0001863127",
  "entityName": "Tyra Biosciences, Inc.",
  "fiscal_years": [
    {
      "accn": "0001193125-26-085490",
      "filed": "2026-03-02",
      "fiscal_year": 2025,
      "form": "10-K",
      "fundamental_units": {
        "capex": "USD",
        "cash": "USD",
        "eps_diluted": "USD/shares",
        "free_cash_flow": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "capex": 141000.0,
        "cash": 77387000.0,
        "eps_diluted": -2.01,
        "free_cash_flow": -95283000.0,
        "net_income": -119947000.0,
        "operating_cash_flow": -95142000.0,
        "operating_income": -132762000.0,
        "stockholders_equity": 259177000.0,
        "total_assets": 282609000.0,
        "total_liabilities": 23432000.0
      },
      "period_end": "2025-12-31",
      "ratio_units": {
        "leverage": "ratio",
        "roa_avg2y": "ratio",
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio",
        "roe_period_end": "ratio"
      },
      "ratios": {
        "leverage": 0.0904092569942549,
        "roa_avg2y": -0.3712569660784286,
        "roa_period_end": -0.4244273890781964,
        "roe_avg2y": -0.39827801463654355,
        "roe_period_end": -0.4627995539727677
      }
    },
    {
      "accn": "0001193125-26-085490",
      "filed": "2026-03-02",
      "fiscal_year": 2024,
      "form": "10-K",
      "fundamental_units": {
        "capex": "USD",
        "cash": "USD",
        "eps_diluted": "USD/shares",
        "free_cash_flow": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "capex": 664000.0,
        "cash": 91966000.0,
        "eps_diluted": -1.51,
        "free_cash_flow": -70438000.0,
        "net_income": -86481000.0,
        "operating_cash_flow": -69774000.0,
        "operating_income": -104177000.0,
        "stockholders_equity": 343151000.0,
        "total_assets": 363558000.0,
        "total_liabilities": 20407000.0
      },
      "period_end": "2024-12-31",
      "ratio_units": {
        "leverage": "ratio",
        "roa_avg2y": "ratio",
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio",
        "roe_period_end": "ratio"
      },
      "ratios": {
        "leverage": 0.059469446395318676,
        "roa_avg2y": -0.2934468922575774,
        "roa_period_end": -0.2378740118495536,
        "roe_avg2y": -0.3159625365126513,
        "roe_period_end": -0.25202024764608
      }
    },
    {
      "accn": "0001193125-26-085490",
      "filed": "2026-03-02",
      "fiscal_year": 2023,
      "form": "10-K",
      "fundamental_units": {
        "capex": "USD",
        "cash": "USD",
        "eps_diluted": "USD/shares",
        "free_cash_flow": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "capex": 770000.0,
        "cash": 58006000.0,
        "eps_diluted": -1.62,
        "free_cash_flow": -50909000.0,
        "net_income": -69134000.0,
        "operating_cash_flow": -50139000.0,
        "operating_income": -79945000.0,
        "stockholders_equity": 204262000.0,
        "total_assets": 225857000.0,
        "total_liabilities": 21595000.0
      },
      "period_end": "2023-12-31",
      "ratio_units": {
        "leverage": "ratio",
        "roa_avg2y": "ratio",
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio",
        "roe_period_end": "ratio"
      },
      "ratios": {
        "leverage": 0.10572206284086125,
        "roa_avg2y": -0.28101081623777024,
        "roa_period_end": -0.3060963352917997,
        "roe_avg2y": -0.29922244752656946,
        "roe_period_end": -0.33845747128687664
      }
    },
    {
      "accn": "0000950170-25-046124",
      "filed": "2025-03-27",
      "fiscal_year": 2022,
      "form": "10-K",
      "fundamental_units": {
        "capex": "USD",
        "cash": "USD",
        "eps_diluted": "USD/shares",
        "free_cash_flow": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "capex": 559000.0,
        "cash": 251213000.0,
        "eps_diluted": -1.32,
        "free_cash_flow": -50844000.0,
        "net_income": -55325000.0,
        "operating_cash_flow": -50285000.0,
        "operating_income": -58927000.0,
        "stockholders_equity": 257829000.0,
        "total_assets": 266181000.0,
        "total_liabilities": 8352000.0
      },
      "period_end": "2022-12-31",
      "ratio_units": {
        "leverage": "ratio",
        "roa_avg2y": "ratio",
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio",
        "roe_period_end": "ratio"
      },
      "ratios": {
        "leverage": 0.032393563175593124,
        "roa_avg2y": -0.19314623255749003,
        "roa_period_end": -0.20784729188033707,
        "roe_avg2y": -0.19774253617982507,
        "roe_period_end": -0.2145802062607387
      }
    },
    {
      "accn": "0000950170-24-033461",
      "filed": "2024-03-19",
      "fiscal_year": 2021,
      "form": "10-K",
      "fundamental_units": {
        "capex": "USD",
        "cash": "USD",
        "eps_diluted": "USD/shares",
        "free_cash_flow": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "capex": 661000.0,
        "cash": 302182000.0,
        "eps_diluted": -1.91,
        "free_cash_flow": -24406000.0,
        "net_income": -26294000.0,
        "operating_cash_flow": -23745000.0,
        "operating_income": -26288000.0,
        "stockholders_equity": 301737000.0,
        "total_assets": 306701000.0,
        "total_liabilities": 4964000.0
      },
      "period_end": "2021-12-31",
      "ratio_units": {
        "leverage": "ratio",
        "roa_avg2y": "ratio",
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio",
        "roe_period_end": "ratio"
      },
      "ratios": {
        "leverage": 0.016451412985480734,
        "roa_avg2y": -0.16295644413594784,
        "roa_period_end": -0.08573170612420566,
        "roe_avg2y": -0.18253447599609857,
        "roe_period_end": -0.08714211382760484
      }
    },
    {
      "accn": "0000950170-23-009181",
      "filed": "2023-03-22",
      "fiscal_year": 2020,
      "form": "10-K",
      "fundamental_units": {
        "capex": "USD",
        "cash": "USD",
        "free_cash_flow": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "capex": 312000.0,
        "cash": 15224000.0,
        "free_cash_flow": -8075000.0,
        "net_income": -9336000.0,
        "operating_cash_flow": -7763000.0,
        "operating_income": -9297000.0,
        "stockholders_equity": -13638000.0,
        "total_assets": 16011000.0,
        "total_liabilities": 1998000.0
      },
      "period_end": "2020-12-31",
      "ratio_units": {
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio"
      },
      "ratios": {
        "roa_period_end": -0.5830991193554431,
        "roe_avg2y": 1.01594210784047
      }
    },
    {
      "accn": "0000950170-22-002814",
      "filed": "2022-03-03",
      "fiscal_year": 2019,
      "form": "10-K",
      "fundamental_units": {
        "stockholders_equity": "USD"
      },
      "fundamentals": {
        "stockholders_equity": -4741000.0
      },
      "period_end": "2019-12-31",
      "ratios": {}
    }
  ],
  "latest_filing": {
    "accn": "0001193125-26-085490",
    "filed": "2026-03-02",
    "form": "10-K"
  },
  "note": "Static grepcent export of verified SEC companyfacts-derived values. Monetary values are raw reported units from grepcent's resolved facts; no scaling and no FX conversion. Capex, dividends, and buybacks are reported as positive outflow magnitudes. ROE/ROA include both period-end basis (site-consistent) and average-of-two-years basis where the prior-year denominator exists.",
  "schema_version": "1",
  "sic": "2834",
  "sic_description": "Pharmaceutical Preparations",
  "source_urls": {
    "sec_companyfacts": "https://data.sec.gov/api/xbrl/companyfacts/CIK0001863127.json",
    "sec_submissions": "https://data.sec.gov/submissions/CIK0001863127.json"
  },
  "ticker": "TYRA"
}